In-stent Restenosis after Drug-eluting Stent Implantation in Rheumatoid Arthritis: Possible Protective Effect of Methotrexate.

In-stent Restenosis after Drug-eluting Stent Implantation in Rheumatoid Arthritis: Possible Protective Effect of Methotrexate. J Rheumatol. 2018 Aug 01;: Authors: Kwon OC, Oh JS, Kim YG Abstract Patients with rheumatoid arthritis (RA) are at higher risk of cardiovascular events compared with the general population. Therefore, these patients with RA have a greater chance of undergoing percutaneous coronary intervention (PCI). PMID: 30068765 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30068765?dopt=Abstract

Source: J Rheumatol - August 1, 2018 Category: Rheumatology Authors: Kwon OC, Oh JS, Kim YG Tags: J Rheumatol Source Type: research